About Prometheus
The Prometheus Name
Executive Management
Board of Directors
Location and Directions
Community Sponsorship
Contact Us
Email Billing Support
Email Client Services
Investor Relations
Corporate Governance
Executive Management
Board of Directors
News Releases
Conference Presentations
E-mail Alerts
Products & Services
Therapeutics
LOTRONEX
®
ENTOCORT
®
EC
Helidac
®
Imuran
®
Mercaptopurine
Ridaura
®
Trandate
®
Zyloprim
®
Diagnostics
IBS Diagnostic
IBD Serology
Celiac
Thiopurine Monitoring
TPMT Testing
Liver Fibrosis
Serum Infliximab/HACA
Lactose Intolerance
NOD2/CARD15
H. pylori
Oncology
Healthcare Professionals
Materials and Forms
Online Resources
Certifications and Licensing
Schedule of Events
ProNet Overview
Billing Support
Business Development
External Submission Form
Careers
The Prometheus Culture
Employee Benefits
Join our Team
Job Search
Post Resume
Returning Candidates
Manager Center
Notice to Recruiters
We are committed to improving lives through the delivery of innovative diagnostic and therapeutic products that enable clinicians to provide optimal care for their patients.
Latest
News
1/26/2010
Prometheus Acquires Exclusive Rights to PROLEUKIN® (aldesleukin) in the U.S.
1/7/2010
Prometheus Completes $260 Million Financing
10/20/2009
Prometheus Awarded Patent Related to Genetic Testing for IBD
- the first do it yourself saliva-based genetic test dedicated
to celiac disease
Home
Contact Us
Site Map
Privacy Policy
Legal Disclaimer
Recommend Prometheus
Reference within this site to any specific advertisement or promotion of a non-Prometheus product
does not constitute an endorsement or recommendation by Prometheus.
© 2008 Prometheus. All Rights Reserved. Mkt Doc 100 Rev. F